These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 11256592)

  • 1. Therapeutic target discovery using Caenorhabditis elegans.
    Link EM; Hardiman G; Sluder AE; Johnson CD; Liu LX
    Pharmacogenomics; 2000 May; 1(2):203-17. PubMed ID: 11256592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling molecular and cellular aspects of human disease using the nematode Caenorhabditis elegans.
    Silverman GA; Luke CJ; Bhatia SR; Long OS; Vetica AC; Perlmutter DH; Pak SC
    Pediatr Res; 2009 Jan; 65(1):10-8. PubMed ID: 18852689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Caenorhabditis elegans: a versatile platform for drug discovery.
    Artal-Sanz M; de Jong L; Tavernarakis N
    Biotechnol J; 2006 Dec; 1(12):1405-18. PubMed ID: 17109493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Caenorhabditis elegans: a powerful tool for drug discovery].
    Jia XH; Cao C
    Yao Xue Xue Bao; 2009 Jul; 44(7):687-94. PubMed ID: 19806904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endocrine targets for pharmacological intervention in aging in Caenorhabditis elegans.
    Gill MS
    Aging Cell; 2006 Feb; 5(1):23-30. PubMed ID: 16441840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modeling human diseases in Caenorhabditis elegans.
    Markaki M; Tavernarakis N
    Biotechnol J; 2010 Dec; 5(12):1261-76. PubMed ID: 21154667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Caenohabditis elegans in Parkinson's disease drug discovery: addressing an unmet medical need.
    Nass R; Merchant KM; Ryan T
    Mol Interv; 2008 Dec; 8(6):284-93. PubMed ID: 19144901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contributions from Caenorhabditis elegans functional genetics to antiparasitic drug target identification and validation: nicotinic acetylcholine receptors, a case study.
    Brown LA; Jones AK; Buckingham SD; Mee CJ; Sattelle DB
    Int J Parasitol; 2006 May; 36(6):617-24. PubMed ID: 16620825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-throughput RNAi in Caenorhabditis elegans: genome-wide screens and functional genomics.
    Sugimoto A
    Differentiation; 2004 Mar; 72(2-3):81-91. PubMed ID: 15066188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The art and design of genetic screens: caenorhabditis elegans.
    Jorgensen EM; Mango SE
    Nat Rev Genet; 2002 May; 3(5):356-69. PubMed ID: 11988761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Approaches to identify endogenous peptides in the soil nematode Caenorhabditis elegans.
    Husson SJ; Clynen E; Boonen K; Janssen T; Lindemans M; Baggerman G; Schoofs L
    Methods Mol Biol; 2010; 615():29-47. PubMed ID: 20013198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolating genes involved with genotoxic drug response in the nematode Caenorhabditis elegans using genome-wide RNAi screening.
    Schøler LV; Møller TH; Nørgaard S; Vestergaard L; Olsen A
    Methods Mol Biol; 2012; 920():27-38. PubMed ID: 22941594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relevance of Caenorhabditis elegans genetics for understanding human psychiatric disease.
    Wang X; Sliwoski GR; Buttner EA
    Harv Rev Psychiatry; 2011; 19(4):210-8. PubMed ID: 21790269
    [No Abstract]   [Full Text] [Related]  

  • 14. Caenorhabditis elegans as a model system for triplet repeat diseases.
    Voisine C; Hart AC
    Methods Mol Biol; 2004; 277():141-60. PubMed ID: 15201454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [C. elegans as a model for human inherited degenerative diseases].
    Ségalat L; Néri C
    Med Sci (Paris); 2003 Dec; 19(12):1218-25. PubMed ID: 14691746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional characterisation of a cyst nematode acetylcholinesterase gene using Caenorhabditis elegans as a heterologous system.
    Costa JC; Lilley CJ; Atkinson HJ; Urwin PE
    Int J Parasitol; 2009 Jun; 39(7):849-58. PubMed ID: 19367833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolution of dnmt-2 and mbd-2-like genes in the free-living nematodes Pristionchus pacificus, Caenorhabditis elegans and Caenorhabditis briggsae.
    Gutierrez A; Sommer RJ
    Nucleic Acids Res; 2004; 32(21):6388-96. PubMed ID: 15576683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional genomic approaches in C. elegans.
    Lamitina T
    Methods Mol Biol; 2006; 351():127-38. PubMed ID: 16988431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-throughput screening of small molecules for bioactivity and target identification in Caenorhabditis elegans.
    Burns AR; Kwok TC; Howard A; Houston E; Johanson K; Chan A; Cutler SR; McCourt P; Roy PJ
    Nat Protoc; 2006; 1(4):1906-14. PubMed ID: 17487175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The year of the worm.
    Plasterk RH
    Bioessays; 1999 Feb; 21(2):105-9. PubMed ID: 10193184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.